Solventum Corporation is a healthcare company that was founded in 2023 following a spin-off from 3M’s Health Care Business. The company is headquartered in Saint Paul, Minnesota, USA. It officially launched as an independent entity in April 2024 and is publicly traded on the New York Stock Exchange under the ticker SOLV.

With a history rooted in more than 70 years of healthcare innovation through its legacy with 3M, Solventum focuses on delivering advanced healthcare products and services. Its offerings include advanced wound care, surgical solutions, and health information technology systems that serve healthcare professionals, dental professionals, and the biopharmaceutical industry.

The company name “Solventum” symbolizes “solving” and “momentum,” reflecting its mission to continuously find breakthrough solutions and accelerate innovation in healthcare. Their logo embodies this commitment, representing limitless potential and a responsive, caring approach to solving patient and healthcare professional challenges.

Solventum operates with more than 22,000 professionals worldwide and achieved approximately $8.3 billion in sales in 2024. It has also filed numerous patents related to medical treatments, equipment, and technologies, signaling its emphasis on research and development.

The spin-off from 3M was designed to allow both companies to pursue tailored growth strategies independently. Solventum aims to enable better, smarter, and safer healthcare to improve lives globally, continuing a legacy of innovation and customer-focused solutions.